Cite
HARVARD Citation
Minetto, P. et al. (2019). Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information. British journal of haematology. pp. 457-460. [Online].